Akèy › Kansè Endomèt › Georgia › Augusta
Etid klinik pou Kansè Endomèt nan Augusta, GA
7 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Augusta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Ap rekriteFaz 3
- Augusta University Medical Center, Augusta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
- Augusta University, Augusta
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Ap rekriteFaz 2
- Augusta University Medical Center, Augusta
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
- Georgia Cancer Center at Augusta University, Augusta
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
- Augusta University Georgia Cancer Center, Augusta
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Ap rekriteFaz 1/2
- Georgia Cancer Center, Augusta
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Ap rekriteFaz 2
- Augusta University, Augusta
Etid Kansè Endomèt nan lòt vil
- Houston, TX68 etid
- New York City, NY52 etid
- Boston, MA50 etid
- Arlington, VA39 etid
- Nashville, TN38 etid
- Los Angeles, CA34 etid
- St. Louis, MO29 etid
- Philadelphia, PA28 etid
- San Antonio, TX27 etid
- Queens, NY25 etid
- Columbus, OH25 etid
- Chicago, IL25 etid
Lòt etid nan Augusta
- Leksemi mieloïd egi10 etid
- Kansè ovè8 etid
- Kansè (tout kalite)7 etid
- Maladi selil fòs5 etid
- Kansè nan tete5 etid
- Miasteni grav4 etid
- Kansè san4 etid
- Limfòm Burkitt4 etid
- Limfom Difize Gwo Selil B4 etid
- Lukemi miyoyid kwonik4 etid
- Limfòm Non-Hodgkin4 etid
- Kansè kol4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.